Back to search

Canada· CA-DIN-02466325

TOPICAL HAPTEN GEL

A tests for allergic diseases product containing haptens, registered in Canada by DORMER LABORATORIES INC.. The same ATC class is registered in 11 of our 19 countries.

ATC V04CL

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedTOPICAL HAPTEN GELATCV04CLREGISTER NO.CA-DIN-02466325PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Haptens is registered in 11 of 19 countries.

Countries holding a registration under ATC V04CL (tests for allergic diseases), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 7 of them publish a price we can compare per daily dose

Haptens · ATC V04CL

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
HAPTENS
Manufacturer
DORMER LABORATORIES INC.
Country
Canada (CA)
ATC code
V04CL
ATC class
Tests for allergic diseases
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3b52935f-d813-4060-bf6b-6c3d973df50b
GET /v1/drugs/3b52935f-d813-4060-bf6b-6c3d973df50b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02466325",
  "form": "GEL",
  "class": "Human",
  "routes": [
    "TOPICAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "V04CL",
  "schedule": [
    "Schedule D"
  ],
  "drug_code": "95465",
  "strengths": [
    "50 %"
  ],
  "ahfs_class": null,
  "substances": [
    "HAPTENS"
  ],
  "product_categorization": null
}

See everything about haptens.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.